Evaluation du plan cancer 2003-2007 : Rapport final Ministère de la santé et des sports, p.495, 2009. ,
des sports et de la vie associative, Décret n°2005- 1023 du 24 août 2005 relatif au contrat de bon usage des médicaments et des produits et prestations mentionné à l'article L, du code de la sécurité sociale, pp.162-184, 2005. ,
de la jeunesse, des sports et de la vie associative, Circulaire n°DHOS/E2/DSS/1C, 2006. ,
Arrêté du 18 février 2009 pris pour l'application de l'article L. 162-22-7-2 du code de la sécurité sociale 2009 [cité; Disponible à ,
[An overview of the 2001-2002 cancer activity in the 30 French Regional and University Hospitals, based on PMSI data]. Bull Cancer, pp.94-915, 2007. ,
Cancer incidence and mortality in France over the period 1980???2005, Revue d'??pid??miologie et de Sant?? Publique, vol.56, issue.3, pp.159-175, 2008. ,
DOI : 10.1016/j.respe.2008.03.117
URL : https://hal.archives-ouvertes.fr/inserm-00338335
Classification statistique internationale des maladies et des problèmes de santé connexes : CIM-10 Méthodologie générale d'élaboration des protocoles thérapeutiques hors GHS. 2007. p. 5. 11. Institut National du Cancer, Référentiels de bon usage hors GHS : Cancers bronchiques et mesotheliomes pleuraux malin. 2009. p. 59. 12. Institut National du Cancer, Référentiels de bon usage hors GHS : Cancers digestifs, Genève. 167. 10. AFSSAPS/HAS/INCa 53. 13. Institut National du Cancer, Référentiels de bon usage hors GHS : Oncologie thoracique, p.53, 1995. ,
Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme, Journal of Clinical Oncology, vol.25, issue.30, pp.25-4722, 2007. ,
DOI : 10.1200/JCO.2007.12.2440
Site Parhtage, Janvier, 2009. ,
Is it possible to estimate the incidence of breast cancer from medico-administrative databases?, European Journal of Epidemiology, vol.26, issue.10, pp.681-688, 2008. ,
DOI : 10.1201/9781420010138
URL : https://hal.archives-ouvertes.fr/inserm-00338952
Référentiel de bon usage and Thésaurus national de cancérologie digestive: analysis of non conform prescriptions in Tenon hospital, Bulletin du cancer, vol.96, issue.2, pp.147-154, 2009. ,
Efficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab plus irinotecan, Journal of Neuro-Oncology, vol.82, issue.3, pp.91-329, 2009. ,
DOI : 10.1016/j.brainresrev.2004.03.001
Gemcitabine?Oxaliplatin Combination in Heavily Pretreated Metastatic Breast Cancer: A Pilot Study on 43 Patients, The Breast Journal, vol.23, issue.2, pp.165-171, 2007. ,
DOI : 10.1093/annonc/mdh351
Stage IIIB non-small cell lung cancer. Optimization of radiotherapy in lung cancer: some interesting questions to be solved, Rev Mal Respir, vol.235, pp.16-61, 2006. ,
Gemcitabine and radiotherapy in non-small cell lung cancer: dolce vita at last! Bull Cancer, pp.94-127, 2007. ,
Randomized Phase III Trial of Capecitabine Compared With Bevacizumab Plus Capecitabine in Patients With Previously Treated Metastatic Breast Cancer, Journal of Clinical Oncology, vol.23, issue.4, pp.792-799, 2005. ,
DOI : 10.1200/JCO.2005.05.098
A phase II study of outpatient first-line paclitaxel, carboplatin, and bevacizumab for advanced-stage epithelial ovarian, peritoneal, and fallopian tube cancer, International Journal of Gynecological Cancer, vol.17, issue.4, pp.771-776, 2007. ,
DOI : 10.1111/j.1525-1438.2007.00886.x
Phase II Trial of Bevacizumab in Persistent or Recurrent Epithelial Ovarian Cancer or Primary Peritoneal Cancer: A Gynecologic Oncology Group Study, Journal of Clinical Oncology, vol.25, issue.33, pp.25-5165, 2007. ,
DOI : 10.1200/JCO.2007.11.5345
Phase II Study of Bevacizumab in Patients With Platinum-Resistant Ovarian Cancer or Peritoneal Serous Cancer, Journal of Clinical Oncology, vol.25, issue.33, pp.25-5180, 2007. ,
DOI : 10.1200/JCO.2007.12.0782
Bevacizumab combination therapy in recurrent, platinum-refractory, epithelial ovarian carcinoma, Cancer, vol.5, issue.1, pp.83-89, 2006. ,
DOI : 10.1016/S0002-9440(10)64467-7
Bevacizumab plus cyclophosphamide in heavily pretreated patients with recurrent ovarian cancer???, Gynecologic Oncology, vol.107, issue.2 ,
DOI : 10.1016/j.ygyno.2007.07.017